Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation-Reference-Cited by-同舟云学术

Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation

Published:2020-10 Issue:10260 Volume:396 Page:1399-1412
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Takahashi Kuniaki,Serruys Patrick W,Fuster Valentin,Farkouh Michael E,Spertus John A,Cohen David J,Park Seung-Jung,Park Duk-Woo,Ahn Jung-Min,Kappetein Arie Pieter,Head Stuart J,Thuijs Daniel JFM,Onuma Yoshinobu,Kent David M,Steyerberg Ewout W,van Klaveren David

Publisher

Elsevier BV

Subject

General Medicine

Reference60 articles.

1. 2018 ESC/EACTS Guidelines on myocardial revascularization;Neumann;Eur Heart J,2018

2. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase;Ong;Am Heart J,2006

3. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease;Serruys;N Engl J Med,2009

4. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial;Kappetein;Eur Heart J,2011

5. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial;Mohr;Lancet,2013

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital and Physician Variability in Revascularization Decisions and Outcomes for Patients With 3‐Vessel and Left Main Coronary Artery Disease: A Population‐Based Cohort Study;Journal of the American Heart Association;2024-09-09

2. Should We Use Aspirin or P2Y12 Inhibitor Monotherapy in Stable Ischemic Heart Disease?;Current Atherosclerosis Reports;2024-09-07

3. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

4. Clinical Updates in Coronary Artery Disease: A Comprehensive Review;Journal of Clinical Medicine;2024-08-06

5. Outcomes According to Coronary Disease Complexity and Optimal Thresholds to Guide Revascularization Approach;JACC: Cardiovascular Interventions;2024-08